Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2003
11/20/2003CA2484144A1 Eif-5a nucleic acids for inhibiting apoptosis
11/20/2003CA2483914A1 Capsules for dry powder inhalers and methods of making and using same
11/20/2003CA2480488A1 Novel diazabicyclic biaryl derivatives
11/20/2003CA2480378A1 Novel azacyclic ethynyl derivatives
11/20/2003CA2474947A1 Combination of a growth factor and a protease enzyme
11/20/2003CA2462203A1 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/19/2003EP1362911A1 Transgenic animal having drug metabolism enzyme gene and utilization thereof
11/19/2003EP1362848A1 Process for the preparation of vitamin D derivatives
11/19/2003EP1362598A1 Active oxygen generator containing photosensitizer for ultrasonic therapy
11/19/2003EP1362592A1 Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-kB
11/19/2003EP1362589A1 The use of R(+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4- piperidinemethanol for the treatment of sleep disorders
11/19/2003EP1362584A1 Immediate wettability water soluble film or water soluble layer for oral application
11/19/2003EP1362106A2 Streptococcus pyogenes polypeptides and corresponding dna fragments
11/19/2003EP1362061A2 Antibodies that bind both bcma and taci
11/19/2003EP1362048A1 Triazolo compounds as mmp inhibitors
11/19/2003EP1362047A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors
11/19/2003EP1362045A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/19/2003EP1362044A1 Phthalazinone-piperidino-derivatives as pde4 inhibitors
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1361884A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
11/19/2003EP1361882A1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
11/19/2003EP1361880A2 6-substituted pyrido-pyrimidines
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/19/2003EP1179005B1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/19/2003EP1178046B1 Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof
11/19/2003EP1140150B1 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor
11/19/2003EP1117628B1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
11/19/2003EP1117401B1 Antibiotic compositions for treatment of the eye
11/19/2003EP0851753B1 Aerosol compositions
11/19/2003EP0831811B1 Carbazoles for treating microbial infections
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003CN1457257A Extended native chemical ligation
11/19/2003CN1456660A Ginkgo juice extracting method, food and medicine therefrom
11/19/2003CN1456352A Medicinal composition containing fiber eliminating enzyme
11/19/2003CN1456344A Medicine composition for treating sphagitis and preparing method thereof
11/19/2003CN1456343A Medicine composition for treating sphagitis and preparing method thereof
11/19/2003CN1456341A Lung clearing oral liquid preparation for treating viral pneumonia in Children and preparing method thereof
11/19/2003CN1456335A Antiviral medicine composition and application thereof
11/19/2003CN1456293A Biyanling tablets and preparation thereof
11/19/2003CN1456280A Process for treating Pengze fritillary bulb and preparing capsules
11/19/2003CN1456270A Preparation of Baokening effervescent tablets against cough
11/19/2003CN1456268A Preparation of capsules against rhinitis
11/19/2003CN1456266A Preparation of composite south isatis root effervescent tablets
11/19/2003CN1456228A Preparation of cow bezoare snake gall bladder sichuan fritillary bulb
11/19/2003CN1456226A Preparation of acrid rhinitis pills
11/19/2003CN1456214A Preparing method for cough curing pills
11/19/2003CN1456201A Isatidis soft capsule and preparing method thereof
11/19/2003CN1456189A Healthy products for regulating blood fat and removing heat from throat
11/19/2003CN1456152A Lyophilized preparation of civeleth sodium
11/19/2003CN1127954C Use of R(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4- piperidinemethanol for treatment of sleep disorders
11/18/2003US6649658 (−)-Verbenone derivatives
11/18/2003US6649640 Isoxazole compositions useful as inhibitors of ERK
11/18/2003US6649636 Cyclooxygenase inhibitors
11/18/2003US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/18/2003US6649611 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
11/18/2003US6649604 Analgesics; antidiabetic agents; antiinflamamtory agents
11/18/2003US6649600 2,6-Dioxo or dithioxy-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo derivatives; highly potent and selective diuretics
11/18/2003US6649370 Isolated polynucleotide which induces a immune response when administered to a mammal; expression vectors; vaccines
11/18/2003US6649145 Wound healing, treating infections
11/13/2003WO2003093297A2 Protein kinase modulators and methods of use
11/13/2003WO2003093270A1 5-ethyl-imidazo (5,1-f) (1,2,4,) triazin-4 (3h) -ones as phosphodiesterase inhibitors
11/13/2003WO2003093268A1 7-aminoimidazotriazones
11/13/2003WO2003093248A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
11/13/2003WO2003093245A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003093237A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
11/13/2003WO2003093234A1 Melanocortin receptor ligands
11/13/2003WO2003093231A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/13/2003WO2003092699A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
11/13/2003WO2003092690A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003WO2003092686A1 Inhibitors of histone deacetylase
11/13/2003WO2003092678A1 1-substituted imidazole derivatives as nos inhibitors
11/13/2003WO2003092670A1 Bombesin antagonists
11/13/2003WO2003092654A1 Formulations limiting spread of pulmonary infections
11/13/2003WO2003092599A2 Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
11/13/2003WO2003092585A2 Controlled release compositions of estradiol metabolites
11/13/2003WO2003092580A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/13/2003WO2003076417A3 Oxo-azabicyclic compounds
11/13/2003WO2003075826A3 Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthma(obstructive lung disease)
11/13/2003WO2003068968A3 Mutated gene coding for a lat protein and the biological applications thereof
11/13/2003WO2003066621A8 Piperidine derivatives and their use as antagonists of tachykinins
11/13/2003WO2003064447A3 Immune-modulating peptide
11/13/2003WO2003061365A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/13/2003WO2003053966A3 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists
11/13/2003WO2003051392A3 Streptococcus pneumoniae vaccine
11/13/2003WO2003041644A3 Method to treat cystic fibrosis
11/13/2003WO2003041563A3 Neurotransmitter balance chemotherapy
11/13/2003WO2003031459A3 Modulation of the expression of genes dependent on stat-1
11/13/2003WO2003031407A3 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS
11/13/2003WO2003030944A3 Inhibition of stat-1
11/13/2003WO2003029200A3 Compounds useful as reversible inhibitors of cysteine proteases
11/13/2003WO2003018134A3 Bioadhesive compositions and methods for enhanced mucosal drug absorption
11/13/2003WO2003013432A3 Methods of use for novel sulfur containing organic nitrate compounds
11/13/2003WO2003012111A3 Conjugates for the modulation of immune responses
11/13/2003WO2002099115A3 Nucleic acid-associated proteins
11/13/2003WO2002096879A9 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
11/13/2003WO2002057302A8 A virus causing respiratory tract illness in susceptible mammals
11/13/2003WO2002050030A8 Cycloalkylfused [g]-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
11/13/2003WO2002050029A8 Tetracyclic derivatives as spla2 inhibitors
1 ... 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 ... 878